What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Virology, Influenza A virus, Hemagglutinin, Neuraminidase and Virus.
His Virology research integrates issues from Epitope, Antigenicity, Antigen and Binding site.
His Binding site study combines topics from a wide range of disciplines, such as Protein structure, Protein domain and Antibody, Neutralizing antibody.
His Influenza A virus study deals with Influenza A virus subtype H5N1 intersecting with Immunogen, Effector and Orthomyxoviridae.
Xueyong Zhu interconnects Receptor, Sialic acid and Viral protein in the investigation of issues within Hemagglutinin.
He integrates Virus and H5N1 genetic structure in his research.
His most cited work include:
- New world bats harbor diverse influenza A viruses. (790 citations)
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. (699 citations)
- A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. (325 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Virology, Antibody, Epitope, Hemagglutinin and Virus.
His research integrates issues of Antigen and Cell biology in his study of Antibody.
His Epitope research includes elements of Protein structure, Antigenicity and Monoclonal antibody.
The concepts of his Hemagglutinin study are interwoven with issues in Mutagenesis, Receptor and Plasma protein binding.
His work on Orthomyxoviridae as part of general Virus research is frequently linked to H5N1 genetic structure and Trimer, bridging the gap between disciplines.
His research in Influenza A virus intersects with topics in Sialic acid and Neuraminidase.
He most often published in these fields:
- Virology (53.57%)
- Antibody (42.86%)
- Epitope (30.95%)
What were the highlights of his more recent work (between 2018-2021)?
- Virology (53.57%)
- Antibody (42.86%)
- Epitope (30.95%)
In recent papers he was focusing on the following fields of study:
Xueyong Zhu mainly investigates Virology, Antibody, Epitope, Severe acute respiratory syndrome coronavirus 2 and Neutralizing antibody.
His Virology research is multidisciplinary, incorporating perspectives in Monoclonal antibody and Binding site.
His work on Immunoglobulin light chain is typically connected to Coronavirus as part of general Antibody study, connecting several disciplines of science.
Xueyong Zhu works mostly in the field of Epitope, limiting it down to topics relating to Protein structure and, in certain cases, Plasma protein binding, as a part of the same area of interest.
His Influenza A virus study integrates concerns from other disciplines, such as Hemagglutinin, Sialic acid and Neuraminidase.
Xueyong Zhu has researched Neuraminidase in several fields, including Influenza vaccine and Viral protein.
Between 2018 and 2021, his most popular works were:
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. (699 citations)
- Structural basis of a shared antibody response to SARS-CoV-2. (178 citations)
- A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface (81 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Virology, Antibody, Epitope, Influenza A virus and Hemagglutinin.
In Virology, he works on issues like Monoclonal antibody, which are connected to Hamster.
His Antibody research incorporates themes from Protein domain and Binding site.
His Epitope research focuses on Protein structure and how it connects with Plasma protein binding.
His Influenza A virus research integrates issues from Viral protein and Neuraminidase.
In general Virus, his work in Influenza A virus subtype H5N1 is often linked to Trimer linking many areas of study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
